Kontrol Technologies Corp (OTCMKTS:KNRLF) Gets BioCloud U.S. Patent; Advancing Patent Portfolio
The receipt of a patent is almost always seen as a positive for innovative company and especially so for a company like Kontrol Technologies Corp (OTCMKTS:KNRLF), which is a leading player in the emerging smart cities and buildings industry.
Trading Data
On Tuesday, KNRLF stock decreased 8.98% to $0.3000 with more than 18.85K shares, compared to its average volume of 16.87K shares. The stock moved within a range of $0.2835 – 0.3000 after opening trade at $0.3000.
Kontrol Technologies Receives BioCloud U.S. Patent; Advancing Patent Portfolio
The company announced yesterday that it received its very first Kontrol BioCloud patent. In this context, it is also important to add that the company also noted that it was continuing to work on the building of its patent portfolio for Kontrol BioCloud and Kontrol BioWater related technologies. It is going to be interesting to see how the market reacts to the latest development for the company and if there is any major move in the stock.
The Chief Executive Officer of Kontrol Paul Ghezzi spoke about the development as well. He stated that the receipt of the patent was a major development for the company’s technology platform and marked a significant milestone. The patent that was awarded to the company was for an air sampling system and specifically related to the collection chamber present in the system. The innovative system could well prove to be a major constituent of the company’s growing intellectual property portfolio.
